COVID-19 GP Snapshot 5 - The impact of the COVID-19 pandemic on general practice-based HbA1c monitoring in type 2 diabetes

COVID-19 GP Snapshot 5 - The impact of the COVID-19 pandemic on general practice-based HbA1c monitoring in type 2 diabetes

The impact of the COVID-19 pandemic on general practice-based HbA1c monitoring in type 2 diabetes

The aim of this Snapshot is to examine the potential impacts of the COVID-19 pandemic on diabetes care in Australian general practice, by looking at patients with type 2 diabetes using: (a) the volume of HbA1c tests conducted during this period as an indicator of care/access to care; and (b) HbA1c levels as an indicator of glycaemic control.

Suggested citation: Imai C, Hardie R-A, Thomas J, Wabe N, Georgiou A. The impact of the COVID-19 pandemic on general practice-based HbA1c monitoring in type 2 diabetes. General Practice Snapshot. Issue 5: 31 March 2021. Sydney: Macquarie University. https://doi.org/10.25949/Q9BE-BJ06

Content owner: Australian Institute of Health Innovation Last updated: 11 Mar 2024 7:06pm

Back to the top of this page